Organovo is well on the way to achieving the goal of 3D bioprinting entire human organs, with exVive 3D Human Liver Tissue already available and exVive Kidnery Tissue in active development. The path is helped along through partnerships and collaborations with such big names as Merck, L’Oréal, and Yale University. In an interview with Benzinga, Organovo's Ken Murphy outlined some of the various workings of his company, which we've taken an analytical look at to trace their goals and progress. Read about Organovo and Murphy's thoughts here: ttp://3dprint.com/93493/organovos-bioprinting-future/